SP-MHCI-0598-3

EBV EBNA4 657-666, VEITPYKPTW

US$507.00

In stock

Description

About EBV EBNA4 657-666, VEITPYKPTW

The Epstein-Barr Virus (EBV) (strain B95-8) Epstein-Barr nuclear antigen (EBNA) 4 Peptide (IEDB: 68229) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Epstein-Barr nuclear antigen (EBNA) Peptide, H-VEITPYKPTW-OH (Uniprot: P03203 aa: 657-666) from JPT is produced under strict quality control and quality management.

EBV EBNA4 657-666, VEITPYKPTW - Specifications

  • Peptide sequence: H-VEITPYKPTW-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for EBV EBNA4 657-666, VEITPYKPTW

References:
Read References with JPT’s Antigen Peptides
EBV (strain B95-8) EBNA4 657-666, VEITPYKPTW has been described in:
Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection., J Infect Dis, 2005 (PMID: 16206065)
Use of CD107-based cell sorting ex vivo to enrich subdominant CD8+ T cells in culture., Immunol Cell Biol, 2007 (PMID: 17563760)
The nature and extent of contributions by defective ribosome products to the HLA peptidome., Proc Natl Acad Sci U S A, 2014 (PMID: 24715725)

Documentation

Documentation for EBV EBNA4 657-666, VEITPYKPTW

Properties

Properties of EBV EBNA4 657-666, VEITPYKPTW

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Infection
Layout: Freeze-dried in glass vial
Organism: Epstein-Barr Virus (EBV)
Protein Name: Epstein-Barr nuclear antigen (EBNA)
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to EBV EBNA4 657-666, VEITPYKPTW

Information Values
Sequence: H-VEITPYKPTW-OH
Specifications: 10mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote